Guardant Health (GH) EBIAT: 2017-2025
Historic EBIAT for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$92.7 million.
- Guardant Health's EBIAT rose 13.95% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 22.17%. This contributed to the annual value of -$436.4 million for FY2024, which is 8.98% up from last year.
- As of Q3 2025, Guardant Health's EBIAT stood at -$92.7 million, which was up 7.18% from -$99.9 million recorded in Q2 2025.
- In the past 5 years, Guardant Health's EBIAT ranged from a high of -$72.3 million in Q4 2021 and a low of -$229.4 million during Q2 2022.
- In the last 3 years, Guardant Health's EBIAT had a median value of -$102.6 million in 2024 and averaged -$109.4 million.
- Its EBIAT has fluctuated over the past 5 years, first tumbled by 237.30% in 2021, then skyrocketed by 68.28% in 2023.
- Over the past 5 years, Guardant Health's EBIAT (Quarterly) stood at -$72.3 million in 2021, then plummeted by 93.52% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then spiked by 40.65% to -$111.0 million in 2024, then increased by 13.95% to -$92.7 million in 2025.
- Its EBIAT was -$92.7 million in Q3 2025, compared to -$99.9 million in Q2 2025 and -$95.2 million in Q1 2025.